Distinct E2F-mediated transcriptional program regulates p14ARF gene expression

• DOI: 10.1038/sj.emboj.7600836
• Publication Date: 2005-10-06T14:10:13Z
• Authors: Hideyuki Komori; Mitsuru Enomoto; Masataka Nakamura; Ritsuko Iwanaga; Kiyoshi Ohtani
• Keywords: 0303 health sciences; Binding Sites; Transcription, Genetic; Cell Cycle; Electrophoretic Mobility Shift Assay; Fibroblasts; Models, Biological; Retinoblastoma Protein; Cyclin-Dependent Kinases; Cell Line; E2F Transcription Factors; 03 medical and health sciences; Gene Expression Regulation; Cyclin D; Cyclins; Tumor Suppressor Protein p14ARF; Humans; Cyclin D1; Adenovirus E1A Proteins; Gene Silencing; Promoter Regions, Genetic; Protein Binding

The tumor suppressor p14(ARF) gene is induced by ectopically expressed E2F, a positive regulator of the cell cycle. The gene is expressed at low levels in normally growing cells in contrast to high levels in varieties of tumors. How p14(ARF) gene is regulated by E2F in normally growing cells and tumor cells remains obscure. Here we show that regulation of p14(ARF) gene by E2F is distinct from that of classical E2F targets. It is directly mediated by E2F through a novel E2F-responsive element that varies from the typical E2F site. The element responds to E2F activity resulting from ectopic E2F1 expression, inactivation of pRb by adenovirus E1a or shRNA, but not to phosphorylation of pRb by serum stimulation or ectopic cyclin D1/cyclin-dependent kinase-4 expression in normal human fibroblasts. The element has activity in various tumor cells with defective pRb, but not in normally growing cells. These results indicate that the distinct regulation constitutes the basis of p14(ARF) function as a tumor suppressor, discriminating abnormal growth signals caused by defects in pRb function from normal growth signals.